Beneficial effects of metformin in normoglycemic morbidly obese adolescents

Metabolism: Clinical and Experimental

Volumn 50, Issue 12, 2001, Pages 1457-1461

  Kay, Joan P ^a   Alemzadeh, Ramin ^a   Langley, G ^a   D'Angelo L ^a   Smith, P ^a   Holshouser, S ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; METFORMIN; PLACEBO; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADOLESCENT; ADULT DISEASE; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL ANIMAL; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LOW CALORY DIET; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0035655494     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.28078     Document Type: Article

References (40)

1. Hyperinsulinemia in obesity syndromes: Its metabolic consequences and possible etiology
2. Hypothalmic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis
3. Development of VMH obesity: In vivo insulin secretion and tissue insulin sensitivity
4. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity
5. Production of insulin resistance by hyperinsulinaemia in man
6. Acute postchallenge hyperinsulinemia predicts weight gain: A prospective study
7. Intragastric pair-feeding fails to prevent VMH obesity on hyperinsulinism
8. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and vitro in Pima Indians
9. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory cation
10. Effect of metformin on peripheral insulin sensitivity in non-insulin-dependent mellitus
11. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes
12. Different effects of insulin and oral ant-diabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus
13. Biguanides: Basic aspects and clinical uses
14. Role of metformin in treatment of diabetes mellitus
15. Biguanides and NIDDM
16. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin
17. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution
18. Metformin decreases food comsumptions and induces weight loss in subjects with obesity and type II non-insulin-dependent diabetes
19. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
20. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
21. Effect of biguanide treatment in obese children
22. Report of Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
23. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves
24. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
25. Bioelectrical impedance estimation of fat-free body mass in children and youth: A cross-validation study
26. Body composition in 5-18-y-old obese children and adolescents before and after weight reduction as assessed by deuterium dilution and bioelectrical impedance analysis
27. Cellular alteration in liver, skeletal muscle, adipose tissue responsible for insulin resistance in obesity and type II diabetes
28. Beneficial effect of diazoxide in obese hyperinsulinemic adults
29. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
30. Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese zucker rats
31. Validity of reported energy intake in obese and non-obese adolescents
32. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity
33. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen with and without the polycystic ovary syndrome
34. Basal metabolic rate, fat-free mass and body cell mass during energy restriction
35. Effects of sucrose on resting metabolic rate, nitrogen balance, leucine turnover and oxidation during weight loss with low calorie diets
36. Four-component model of body composition in children: Density and hydration of fat-free mass and comparison with simpler models
37. Circulating leptin in normal children and during the dynamic phase of juvenile obesity: Relationship to body fatness, energy metabolism, caloric intake, and sexual dimorphism
38. Acute and chronic effect of insulin on leptin production in humans: Studies in vivo and in vitro
39. Leptin: The tale of an obesity gene